MENU
HOWL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Werewolf Therapeutics (HOWL) Ownership - Who owns Werewolf Therapeutics?
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer... Show more
Profile
Industry
N/A
Address
200 Talcott Avenue
Phone
+1 617 952-0555
Employees
47
Web
https://www.werewolftx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
40.21M
P/E Ratio
N/A
Total Cash
111M
Projected Growth
N/A
Total Debt
37.09M
Revenue
1.89M
Risk (Beta)
0.51
Dividend Yield
N/A
Total Cash/Share
2.48
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
Fundamentals
HOWL
Capitalization
40.2M
P/E Ratio
N/A
Risk (Beta)
0.51
Dividend Yield
N/A
Total Cash
111M
Total Cash/Share
2.48
Total Debt
37.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
1.89M
ROE
N/A
Book Value
73.4M
P/B Ratio
0.52
Cash Flow
N/A
Earnings
-1.63
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
7.45
Current Revenue Per Employee
25400.00
Dividends Per Share - Security
N/A
EBITDA
-64.05M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-46.74
Shares Held By Institutions
46.9M
Shares Outstanding - Current
44.8M
Total Liabilities
53.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-39.385
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
200 Talcott Avenue
Phone
+1 617 952-0555
Employees
47
Web
https://www.werewolftx.com